
Dandelion Science develops a platform that programs brain network dynamics to treat vision impairments and other brain disorders. They combine generative AI with neuromodulation to design non-invasive, programmable therapeutics that target network-level brain activity. The company operates as a deeptech B2B platform working with research institutions, clinical partners, and companies studying neurological conditions. Dandelion holds patents and extensive IP, has research partnerships with the Wyss Center and EPFL, and has received funding from the US National Institutes of Health and the Swiss Innovation Agency.

Dandelion Science develops a platform that programs brain network dynamics to treat vision impairments and other brain disorders. They combine generative AI with neuromodulation to design non-invasive, programmable therapeutics that target network-level brain activity. The company operates as a deeptech B2B platform working with research institutions, clinical partners, and companies studying neurological conditions. Dandelion holds patents and extensive IP, has research partnerships with the Wyss Center and EPFL, and has received funding from the US National Institutes of Health and the Swiss Innovation Agency.